Which growth stocks currently offer the strongest combination of growth, quality, and valuation for a Canadian investor? We took a broad universe of large-cap growth companies, fact-checked the evidence against each company’s most recent quarterly reporting as of August 2026, and scored seven standouts across six weighted criteria: growth, profitability, valuation, competitive advantage, balance sheet quality, and risk/reward.
The result is a ranked list, not just another lineup of “good companies” — and the order changed some of our own assumptions along the way. Taiwan Semiconductor’s manufacturing dominance and margins put it at the top. Nvidia, despite explosive growth, lands second once you weigh in today’s more reasonable valuation. And Alphabet — despite posting the fastest cloud growth of any hyperscaler this quarter — ranks last, for a very specific reason we’ll get into below.
Here’s the full ranking, followed by exactly how each score was built.
The Ranking at a Glance
| Rank | Stock | Score | Key Strength | Main Risk |
|---|---|---|---|---|
| 1 | Taiwan Semiconductor (TSM) | 88/100 | Near-monopoly on leading-edge chip manufacturing, 55.6% net margin | Geopolitical concentration in Taiwan; customer concentration |
| 2 | Nvidia (NVDA) | 83/100 | 85% revenue growth at a near-decade-low valuation | AI accelerator share expected to erode from ~80% toward the mid-70s |
| 3 | Broadcom (AVGO) | 78/100 | AI semiconductor revenue up 143%, with multi-year contracted visibility | Six hyperscale customers drive the large majority of AI growth |
| 4 | Microsoft (MSFT) | 77/100 | Azure reaccelerated to 43% growth after a genuine valuation reset | ~$255–260B in FY2027 capex and finance leases to fund |
| 5 | Amazon (AMZN) | 74/100 | AWS accelerating for a 5th straight quarter, margins expanding | AWS deceleration risk against a much larger capex base |
| 6 | Eli Lilly (LLY) | 70/100 | 48% revenue growth from GLP-1 leadership, outside the AI cycle entirely | Rich valuation, declining realized prices, FDA litigation delay |
| 7 | Alphabet (GOOGL) | 65/100 | Fastest cloud growth of any hyperscaler (Google Cloud +82%) | Free cash flow went negative (-$5.9B) amid record capex |
Why did Nvidia rank below Taiwan Semiconductor despite growing revenue nearly three times faster? Why did Alphabet finish last with the best cloud growth number in the group? Both answers come down to the same discipline: growth alone isn’t the ranking. Read on for exactly how each score breaks down.
How We Scored These 7 Stocks
To move this from a description into an actual ranking, we scored each company across six weighted categories, built entirely from the evidence discussed in each company’s section below.
| Category | Weight |
|---|---|
| Growth | 25% |
| Profitability & Cash Flow | 20% |
| Valuation | 20% |
| Competitive Advantage | 15% |
| Balance Sheet / Financial Quality | 10% |
| Risk/Reward | 10% |
The scores are designed to compare the seven companies using a consistent framework rather than relying on a single metric such as revenue growth or valuation.
Each company was evaluated across growth, profitability and cash flow, valuation, competitive advantage, financial quality, and overall risk/reward. Because these factors cannot always be measured in exactly the same way across different industries, the scores should be viewed as a comparative tool rather than a precise forecast of future returns.
The goal is simple: identify which companies currently offer the strongest overall combination of growth, business quality, valuation, and risk based on the financial information available at the time of this analysis.
#1 Taiwan Semiconductor (TSM) — The Foundry Behind Everyone Else’s Chips
Why it ranks here: TSMC tops this list not because it grew the fastest — it didn’t — but because it’s the rare company that combines strong growth with genuinely exceptional margins and a moat that’s close to unassailable. If Nvidia designs the chips and Broadcom customizes them, TSMC is the company that actually manufactures nearly all of them.
Key numbers:
- Q2 2026 revenue: $40.2 billion, up 33.7% year-over-year in USD (36.0% in local currency)
- Gross margin 67.7%, operating margin 60.3%, net margin 55.6%
- Advanced technologies (7nm and below) now 77% of wafer revenue; 2nm production ramping
- Full-year 2026 guidance: revenue growth slightly above 40% in USD
Why it could outperform: TSMC has historically traded at a lower price-to-earnings multiple than many U.S. software and AI companies despite comparable or superior growth — a gap that has persisted into 2026. Without TSMC’s foundries, Nvidia, Apple, AMD, and Broadcom would have no way to physically produce their most advanced products, which gives it pricing power that shows up directly in that 55.6% net margin.
Biggest risk: Geopolitical concentration — TSMC’s manufacturing base remains concentrated in Taiwan — along with customer concentration, since a small number of large clients account for a substantial share of revenue.
Nvidia isn’t far behind — and on one specific measure, arguably has the stronger case, which is exactly why the next section matters as much as the growth numbers.
#2 Nvidia (NVDA) — Still the AI Leader, Now at a More Reasonable Price
Why it ranks here: Nvidia posted the fastest growth rate of any company on this list, but that alone isn’t why it’s this high — it’s here because 2026 has been an unusual year where the business kept growing explosively while the share price lagged behind that growth, leaving a valuation the article’s own reporting calls close to a decade low.
Key numbers:
- Fiscal Q1 2027 revenue (reported May): $81.6 billion, up 85% year-over-year
- Fiscal Q2 revenue guidance: approximately $91 billion
- NVDA shares up only ~17.7% year-to-date as of early August 2026 — lagging AMD and Micron over the same period
- Forward P/E compressed to roughly 22–24x
Why it could outperform: Nvidia’s AI accelerator market share, currently around 80%, is widely expected to moderate toward the mid-70s as hyperscalers develop more custom silicon and AMD gains ground. That’s a real, structural risk — but the current valuation appears to already reflect meaningfully more caution than the growth numbers alone would suggest, which is arguably the most interesting risk/reward setup in this group on a pure valuation basis.
Biggest risk: Competitive erosion in AI accelerator market share, as custom silicon (which directly benefits Broadcom, below) and AMD’s competing chips both gain traction.
But Nvidia isn’t the only way to play the AI silicon buildout — Broadcom’s numbers make a distinctly different case.
#3 Broadcom (AVGO) — The Custom Silicon Powering the Rest of the AI Buildout
Why it ranks here: Broadcom’s growth rate and revenue visibility are arguably the cleanest of any company on this list — the case for including it, and ranking it this high, is straightforward. What keeps it below Nvidia and TSMC is valuation: this growth already comes at a real, stated premium.
Key numbers:
- Fiscal Q2 2026 revenue: $22.2 billion, up 48% year-over-year
- AI semiconductor revenue: $10.8 billion, up 143%; guided to grow over 200% next quarter
- Full-year AI semiconductor target: $56 billion (~180% growth); 2027 target exceeding $100 billion
- Free cash flow: $10.3 billion, a 46% margin — one of the strongest of any large tech company
Why it could outperform: Much of Broadcom’s AI semiconductor revenue is tied to long-term, multi-generation agreements with hyperscale customers — including Google, Meta, OpenAI, and Anthropic — who rely on Broadcom to design and manufacture custom AI accelerators (ASICs) and the networking silicon that connects large chip clusters. That gives Broadcom exposure to the same AI buildout as Nvidia, through a different, complementary part of the stack, with unusually high visibility into future revenue.
Biggest risk: Customer concentration — Broadcom has described its AI growth as substantially dependent on six core hyperscale customers, and any pullback from even one could have an outsized impact.
Microsoft, in fourth, actually posted the slowest headline revenue growth of any technology name above it on this list — so why does it still make the top half? The answer is almost entirely about valuation.
#4 Microsoft (MSFT) — A Quality Compounder That Got Cheaper
Why it ranks here: Microsoft’s growth is real but not the fastest here. What earns it fourth place is something none of the three names above it can claim as clearly: a genuine valuation reset in the middle of continued strong growth, after shares fell roughly 19% year-to-date heading into its most recent report.
Key numbers:
- Fiscal Q4 2026 revenue (reported July 29): $90.0 billion, up 18% year-over-year
- Azure and other cloud services grew 43% — reaccelerating from the prior quarter, pushing full-year Azure revenue past $100 billion for the first time
- Microsoft 365 Copilot surpassed 30 million paid seats, up from 20 million the prior quarter
- Shares jumped nearly 9% on the earnings release, adding roughly $260 billion in market value in a single session
Why it could outperform: That earlier pullback means Microsoft isn’t trading at the stretched multiples some mega-caps carried earlier in the AI cycle, even after its post-earnings rally — a rare combination of reaccelerating growth and a reset valuation.
Biggest risk: The sheer scale of its capital commitments — guidance points to roughly $255–260 billion in fiscal 2027 capital expenditures and finance leases, which will need to keep converting into Azure growth for the market to stay comfortable with the pace of spending.
Amazon had, by this same reporting, the most complete mega-cap quarter of the entire earnings season — yet it ranks fifth. Here’s why that’s not a contradiction.
#5 Amazon (AMZN) — The Cloud Story That Convinced the Market
Why it ranks here: Amazon’s quarter was arguably the strongest of any mega-cap this season, and the market’s reaction reflected that clearly. It ranks fifth not because the business is weaker than the names above it, but because — unlike TSMC, Nvidia, Broadcom, and Microsoft — the underlying research for this piece doesn’t include an explicit valuation multiple for Amazon, and we scored that gap honestly rather than assuming a number.
Key numbers:
- Q2 2026 total revenue crossed $200 billion for the first time in a single quarter, up 20% year-over-year
- AWS revenue accelerated to 37% year-over-year growth — a fifth consecutive quarter of acceleration, the fastest pace since 2021
- AWS operating margin expanded to 39.4%; advertising revenue grew 26% to $19.8 billion
- Operating income rose 43% to $27.5 billion; 2026 capex guidance raised to roughly $220 billion from $200 billion
Why it could outperform: When Alphabet and Meta raised capex guidance this same reporting season, their stocks fell — Meta’s by 8–10%. When Amazon raised its capex guidance by an even larger amount, its stock rose about 9.5% and pushed its market cap past $3 trillion for the first time. The distinguishing factor was credibility: AWS’s growth rate accelerated rather than decelerated even as spending rose, giving investors a clear, current link between capital deployed and revenue generated.
Biggest risk: If AWS growth were to decelerate from here while the elevated capex pace continues, the market’s current confidence could reverse quickly — as it has for peers.
#6 Eli Lilly (LLY) — Healthcare Growth That Doesn’t Depend on the AI Cycle
Why it ranks here: Eli Lilly’s growth rate is genuinely comparable to the fastest technology names on this list, which is remarkable for a company of its size. It ranks sixth rather than higher because that growth already comes at a stated rich valuation relative to traditional pharmaceutical peers, alongside real, sector-specific headwinds. Its role on this list is different from the six technology names above it: a structural growth catalyst that has nothing to do with AI infrastructure spending — valuable diversification within an otherwise concentrated group.
Key numbers:
- Q2 2026 revenue (reported August 5): $23.0 billion, up 48% year-over-year
- Mounjaro revenue up 91% to $9.9 billion; Zepbound up 44% to $4.9 billion
- Gross margin expanded to 86.3%
- Full-year 2026 revenue guidance raised to $85–87 billion, from a prior $82–85 billion
Why it could outperform: The quarter also marked the first to include sales of Foundayo, Lilly’s newly approved obesity pill — an additional growth driver layered on top of its two existing GLP-1 franchises.
Biggest risk: The stock has historically carried a rich valuation relative to pharmaceutical peers, and realized prices for Mounjaro and Zepbound have been declining even as volume grows. Add rising international GLP-1 competition and ongoing litigation with the FDA over the regulatory pathway for retatrutide — which has pushed back its expected filing timeline — and the risks here are concrete, not hypothetical.
That leaves Alphabet in seventh — despite posting the fastest cloud growth rate of any hyperscaler on this list. Numbers don’t get much more counter-intuitive than that, so it’s worth explaining carefully.
#7 Alphabet (GOOGL) — The Fastest Cloud Growth, With a Live Valuation Debate
Why it ranks here: Alphabet posted the single fastest cloud growth rate of any hyperscaler this earnings season — and still finishes last. The reason is free cash flow: this is the only company on this list whose free cash flow went negative this quarter, and the market itself sold the stock off despite the beat. That’s a genuine tension worth understanding rather than glossing over.
Key numbers:
- Q2 2026 revenue rose 24% year-over-year to $119.8 billion
- Google Cloud revenue surged 82% to $24.8 billion, with cloud operating margin more than tripling to 35.6%
- Search revenue grew 17% to $63.3 billion; operating income rose 30% to $40.8 billion
- Capital expenditures hit a record $44.9 billion for the quarter, pushing free cash flow to -$5.9 billion; full-year capex guidance raised to $195–205 billion from $180–190 billion, with management warning 2027 spending would rise significantly further
Why it could outperform: Alphabet’s core search business remains an extraordinarily profitable cash engine, and its cloud acceleration is arguably the most impressive of any company on this list on a growth-rate basis alone.
Biggest risk: The negative free cash flow this quarter, combined with an unusually large forward capex commitment, means the investment case for Alphabet currently depends more than most on continued conversion of that spending into durable, high-margin cloud revenue over the next several quarters — a bet the market is clearly still debating in real time. Alphabet also lacks an explicit valuation multiple in the source reporting for this piece.
A Note on Concentration Risk
Five of the seven companies on this list — Nvidia, Microsoft, Amazon, Alphabet, and Broadcom — are directly tied to the same underlying trend: the buildout of AI infrastructure. That’s a deliberate outcome of the screening methodology, not an oversight. The strongest growth, quality, and revenue visibility currently available in global large-cap equities happens to be concentrated in this trend, and forcing artificial sector diversification into the list would have meant including weaker candidates simply to check a box.
That said, investors should treat this concentration as a real portfolio consideration, not a footnote. If AI infrastructure spending were to slow meaningfully, or if the revenue these companies expect from that spending failed to materialize as quickly as guided, several of these positions could be affected simultaneously, in the same direction, at the same time. This is precisely why Eli Lilly’s inclusion matters beyond its own merits — it represents a structurally different risk driver within the list. Investors relying heavily on this list should still think carefully about their overall portfolio concentration, both within AI-related names and relative to their broader holdings, including Canadian equities.
TSX
This concentration is also worth understanding in the context of the TSX itself. As of July 2026, financials alone represent roughly 31% of the S&P/TSX Composite, and combined with energy and materials, these three sectors make up somewhere between 60% and 65% of the entire index. That concentration has genuine advantages — Canadian banks and energy producers have delivered real strength through 2026 — but it also means the TSX offers very little direct exposure to the AI, cloud, and next-generation healthcare trends behind every stock on this list. That’s the structural reason many Canadian investors choose to complement domestic holdings with global growth names like these.
How to Invest in These Companies (For Canadian Investors)
Canadian investors have two broad paths to gaining exposure to companies like these: buying individual shares directly, or gaining diversified exposure through an ETF.
Buying the Stocks Directly
All seven companies above trade on U.S. exchanges and can be purchased through any Canadian brokerage in a TFSA, RRSP, or non-registered account. Buying individual stocks offers concentrated exposure to the specific companies an investor believes in most, but it also means company-specific risk is not diversified away — a disappointing quarter from any single name can meaningfully affect a concentrated position in a way it would not affect a diversified fund.
ETF Alternatives
For investors who want exposure to this theme without picking individual winners, several Canadian-listed ETFs provide diversified access.
VFV — Vanguard S&P 500 Index ETF. VFV tracks the S&P 500 and includes meaningful weightings in most of the companies discussed above (Nvidia, Microsoft, Amazon, Alphabet, Broadcom, and Eli Lilly are all S&P 500 constituents), alongside hundreds of other large U.S. companies. It offers very low fees and broad diversification, though its technology weighting is naturally lower than a pure growth or Nasdaq-focused fund, since it also includes financials, healthcare, industrials, and other sectors in proportion to their S&P 500 weight.
QQC — Invesco NASDAQ-100 Index ETF (CAD-hedged or unhedged, depending on share class). QQC tracks the Nasdaq-100, which is far more concentrated in technology and growth companies than the S&P 500, and includes Nvidia, Microsoft, Amazon, Alphabet, and Broadcom among its largest holdings. For investors who specifically want to maximize their weighting toward large-cap technology and AI-related growth, QQC generally offers more concentrated exposure than VFV. Eli Lilly, as a healthcare company, is not included in the Nasdaq-100.
The trade-off between individual stocks and ETFs is worth stating plainly: individual stocks offer the potential for outsized returns if you correctly identify the strongest performers, but carry meaningfully higher company-specific risk. ETFs sacrifice some of that upside concentration in exchange for instant diversification across dozens or hundreds of companies, which reduces the damage any single disappointing quarter can do to a portfolio. Neither approach is inherently better — the right choice depends on an investor’s risk tolerance, time available for research, and conviction level in specific companies versus a broader trend.
Tax Considerations for Canadian Investors
The account you hold U.S. stocks in has a real impact on your after-tax returns. The following is general educational information based on current Canada-U.S. tax treaty provisions and is not personalized tax advice — rules can be nuanced depending on individual circumstances, and investors should consult a tax professional for guidance specific to their situation.
U.S. Stocks in an RRSP
Under the Canada-U.S. tax treaty, dividends paid by U.S. companies held within an RRSP (or RRIF) are exempt from the 15% U.S. non-resident withholding tax that would otherwise apply. This exemption is specific to retirement accounts recognized under the treaty and does not extend to a TFSA. For this reason, an RRSP is often considered a more tax-efficient place to hold U.S. dividend-paying stocks specifically.
U.S. Stocks in a TFSA
The TFSA does not benefit from the same treaty exemption, so the 15% U.S. withholding tax still applies to dividends paid on U.S. stocks held in a TFSA. However, the TFSA’s core advantage remains fully intact: all capital gains realized within a TFSA are completely tax-free in Canada, with no reporting required. For growth companies that pay little or no dividend — a description that applies to several names on this list, including Amazon and Alphabet — the drag from U.S. withholding tax is minimal, since there’s little or no dividend income to withhold tax on in the first place. This makes the TFSA a reasonable venue for growth-oriented, low-dividend positions.
Non-Registered Accounts
In a non-registered account, the 15% U.S. withholding tax applies to dividends, but Canadian investors can generally claim a foreign tax credit on their Canadian tax return to avoid double taxation, since the dividend income is also taxable in Canada. Capital gains in a non-registered account are taxable in Canada as well, though only 50% of a capital gain is currently included in taxable income under Canadian tax rules.
Investing in Growth Stocks in a Volatile Market
2026 has been a reminder that even exceptional companies can see sharp, fast stock price swings. Several of the companies on this list — Meta, Alphabet, and Microsoft among the ones discussed here — saw single-day stock moves of 8% or more, in both directions, purely on the market’s interpretation of a single earnings report. This kind of volatility is a normal feature of high-growth investing, not a sign that something has gone wrong.
A gradual entry approach, spreading purchases over weeks or months rather than committing capital all at once, can reduce the risk of poor timing on any single position. Some investors also look to use sharp pullbacks in high-quality names as opportunities to add to positions at more attractive valuations, though this requires genuine conviction in the underlying business rather than simply assuming any decline will be temporary.
Above all, a long-term perspective matters more for this category of investment than almost any other. The structural trends discussed throughout this article — AI infrastructure buildout, cloud computing adoption, and the GLP-1-driven transformation of obesity treatment — are multi-year stories, not single-quarter events, and the companies best positioned to benefit from them are likely to see their fair share of volatile quarters along the way.
Conclusion
Growth stocks remain one of the more powerful tools available for building long-term wealth, and 2026 has reinforced why global diversification matters for Canadian investors specifically: the TSX’s heavy concentration in financials, energy, and materials means genuine exposure to AI infrastructure, cloud computing, and next-generation healthcare has to be sought out elsewhere.
Ranked by growth, profitability, valuation, competitive advantage, balance sheet quality, and risk/reward, Taiwan Semiconductor and Nvidia currently offer the strongest combination on this list — not because they grew the fastest, but because the evidence for their valuation and quality is both the clearest and the most favorable. Amazon’s quarter may have been the most complete of any mega-cap this season, and Alphabet’s cloud growth the fastest — but both currently carry either a valuation gap or a cash-flow red flag serious enough to rank them lower, based strictly on the evidence available.
Investors researching this space should keep watching the same signals highlighted throughout this article for each company: whether revenue growth is translating into real cash flow, whether capital spending is converting into visible, contracted revenue rather than speculative buildout, and whether current valuations still leave reasonable room for error.
As always, a diversified approach — one that considers position sizing, account type, and overall portfolio concentration alongside individual stock selection — remains the more prudent path than concentrating heavily in any single name or theme, however compelling the growth story looks today.
